Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 8 | 2021 | 305 | 1.130 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2016 | 156 | 0.980 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2015 | 177 | 0.660 |
Why?
|
| Adult Stem Cells | 1 | 2016 | 29 | 0.530 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2019 | 798 | 0.480 |
Why?
|
| Cell Proliferation | 4 | 2016 | 1669 | 0.460 |
Why?
|
| Hematopoiesis | 6 | 2021 | 168 | 0.430 |
Why?
|
| Disease Progression | 2 | 2015 | 1469 | 0.400 |
Why?
|
| Neoplastic Stem Cells | 4 | 2019 | 162 | 0.400 |
Why?
|
| Potentially Inappropriate Medication List | 2 | 2020 | 2 | 0.340 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2009 | 86 | 0.340 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2009 | 198 | 0.310 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2015 | 93 | 0.240 |
Why?
|
| Protein Kinase C-alpha | 2 | 2015 | 27 | 0.220 |
Why?
|
| Mice | 12 | 2019 | 11846 | 0.220 |
Why?
|
| Signal Transduction | 2 | 2014 | 3403 | 0.210 |
Why?
|
| Inappropriate Prescribing | 2 | 2020 | 19 | 0.210 |
Why?
|
| GATA2 Transcription Factor | 1 | 2019 | 14 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 3250 | 0.170 |
Why?
|
| Cellular Microenvironment | 1 | 2019 | 29 | 0.160 |
Why?
|
| Pharmacies | 1 | 2019 | 10 | 0.160 |
Why?
|
| Unfolded Protein Response | 1 | 2019 | 43 | 0.160 |
Why?
|
| B-Lymphocytes | 2 | 2015 | 740 | 0.160 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2019 | 48 | 0.160 |
Why?
|
| Animals | 13 | 2019 | 27516 | 0.160 |
Why?
|
| Dyspnea | 1 | 2019 | 76 | 0.150 |
Why?
|
| Mitochondria | 2 | 2019 | 555 | 0.150 |
Why?
|
| Cell Hypoxia | 2 | 2015 | 173 | 0.150 |
Why?
|
| Gene Deletion | 2 | 2015 | 341 | 0.140 |
Why?
|
| Fumarate Hydratase | 1 | 2017 | 6 | 0.140 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 279 | 0.130 |
Why?
|
| Students, Medical | 1 | 2022 | 425 | 0.130 |
Why?
|
| Thymus Neoplasms | 1 | 2016 | 43 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 490 | 0.130 |
Why?
|
| Genomic Instability | 1 | 2016 | 83 | 0.130 |
Why?
|
| Lymphoma, T-Cell | 1 | 2016 | 55 | 0.130 |
Why?
|
| Cells, Cultured | 3 | 2016 | 2887 | 0.130 |
Why?
|
| Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2015 | 20 | 0.130 |
Why?
|
| Cell Survival | 2 | 2015 | 983 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 96 | 0.130 |
Why?
|
| Adenosine Triphosphatases | 1 | 2016 | 155 | 0.130 |
Why?
|
| Mice, Knockout | 5 | 2019 | 2015 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2019 | 433 | 0.130 |
Why?
|
| Dendritic Cells | 1 | 2019 | 451 | 0.130 |
Why?
|
| Protein Kinase C beta | 1 | 2015 | 14 | 0.120 |
Why?
|
| CRISPR-Cas Systems | 1 | 2015 | 83 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2016 | 280 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 2392 | 0.120 |
Why?
|
| Cell Division | 1 | 2016 | 692 | 0.120 |
Why?
|
| Neoplasms | 1 | 2009 | 3062 | 0.120 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 159 | 0.110 |
Why?
|
| Cell Surface Extensions | 1 | 2013 | 11 | 0.110 |
Why?
|
| Megakaryocytes | 1 | 2013 | 36 | 0.110 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 54 | 0.110 |
Why?
|
| Basement Membrane | 1 | 2013 | 55 | 0.100 |
Why?
|
| Cell Dedifferentiation | 1 | 2012 | 8 | 0.100 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2012 | 16 | 0.100 |
Why?
|
| PAX5 Transcription Factor | 1 | 2012 | 33 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 538 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 1576 | 0.100 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2012 | 16 | 0.100 |
Why?
|
| Leukemia | 1 | 2014 | 322 | 0.100 |
Why?
|
| Base Sequence | 1 | 2015 | 2329 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 559 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 245 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3024 | 0.090 |
Why?
|
| Chromatin | 1 | 2013 | 403 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1244 | 0.090 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2009 | 6 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 665 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1452 | 0.080 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2583 | 0.080 |
Why?
|
| Cell Self Renewal | 2 | 2019 | 20 | 0.080 |
Why?
|
| Humans | 12 | 2022 | 89864 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 1283 | 0.070 |
Why?
|
| Nursing Homes | 2 | 2020 | 111 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 557 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 383 | 0.070 |
Why?
|
| Germ-Line Mutation | 1 | 2009 | 347 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 825 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 521 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2019 | 889 | 0.060 |
Why?
|
| Female | 6 | 2019 | 46529 | 0.060 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2015 | 133 | 0.050 |
Why?
|
| Mice, Inbred ICR | 2 | 2013 | 73 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1765 | 0.050 |
Why?
|
| Smartphone | 1 | 2022 | 41 | 0.050 |
Why?
|
| Male | 4 | 2016 | 42614 | 0.040 |
Why?
|
| Psychometrics | 1 | 2022 | 330 | 0.040 |
Why?
|
| Serbia | 1 | 2020 | 3 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2021 | 283 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2019 | 5 | 0.040 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2019 | 17 | 0.040 |
Why?
|
| Citric Acid Cycle | 1 | 2019 | 21 | 0.040 |
Why?
|
| Hexokinase | 1 | 2019 | 19 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2021 | 443 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2019 | 92 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 194 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 146 | 0.040 |
Why?
|
| RNA Interference | 1 | 2019 | 376 | 0.040 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 102 | 0.040 |
Why?
|
| Fumarates | 1 | 2017 | 19 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 854 | 0.030 |
Why?
|
| Chromosome Structures | 1 | 2016 | 2 | 0.030 |
Why?
|
| Metaphase | 1 | 2016 | 24 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2017 | 43 | 0.030 |
Why?
|
| Anaphase | 1 | 2016 | 20 | 0.030 |
Why?
|
| Thymocytes | 1 | 2016 | 31 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2017 | 245 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2766 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2020 | 9185 | 0.030 |
Why?
|
| Leukemic Infiltration | 1 | 2015 | 14 | 0.030 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2015 | 18 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2015 | 57 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 333 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2015 | 110 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 160 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1532 | 0.030 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Nucleoside-Phosphate Kinase | 1 | 2013 | 3 | 0.030 |
Why?
|
| GATA1 Transcription Factor | 1 | 2013 | 18 | 0.030 |
Why?
|
| K562 Cells | 1 | 2013 | 44 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2013 | 77 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 2649 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 310 | 0.030 |
Why?
|
| Inflammation | 1 | 2019 | 981 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 1 | 2013 | 29 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2013 | 53 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1717 | 0.030 |
Why?
|
| Myosin Type II | 1 | 2013 | 50 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2013 | 150 | 0.030 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2012 | 37 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 19230 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2013 | 468 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 387 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2012 | 126 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 284 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2012 | 107 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 895 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 646 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 586 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 961 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2012 | 276 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 449 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 2495 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1227 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 3789 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2013 | 2498 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 6389 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 9327 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 1221 | 0.020 |
Why?
|
| Adult | 1 | 2019 | 26784 | 0.010 |
Why?
|